近日,bwin国际衡阳医学院、肿瘤微环境响应药物研究湖南省重点实验室王震教授团队的卓林胜博士在药物化学领域Top期刊European Journal of Medicinal Chemistry(IF:7.09,药物化学领域影响因子排名第二)上发表了题为“N(14)-substituted Evodiamine Derivatives as Dual Topoisomerase 1/Tubulin-Inhibiting Anti-Gastrointestinal Tumor Agents”(doi.org/10.1016/j.ejmech.2023.115366)的研究性论文。
文章来源:https://mp.weixin.qq.com/s?__biz=MzA3NzUyOTgyNA==&mid=2650875431&idx=1&sn=d7044eb4bfe54551737a1126fa1c889b&chksm=84a511a8b3d298bec72602513e006499155a3bcc798133dc98014144ecc37d042466ef81649f&mpshare=1&scene=23&srcid=04260DlBayxxPcHDHWusJBD6&sharer_sharetime=1682507275418&sharer_shareid=8b62c329cc5e532678ad89fc32464b68#rd